Knockdown of human bid gene expression enhances survival of CD8+ T cells

Immunology Letters

Volumn 122, Issue 1, 2009, Pages 30-36

  Lei, Xiao Ying ^a   Xu, Yan Ming ^a   Wang, Tao ^a   Xie, Qiao Sheng ^a   Jia, Lin Tao ^a   Wang, Li Feng ^a   Jin, Bo Quan ^a   Yan, Zhen ^a   Yao, Li Bo ^a   Yang, An Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adoptive immunotherapy; Bid; siRNA

Indexed keywords

FAS ANTIBODY; PROTEIN BID; RECOMBINANT INTERLEUKIN 2; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ADOPTIVE IMMUNOTHERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIG GENE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MICE; NEOPLASMS; RETROVIRIDAE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

EID: 59649119936     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.10.009     Document Type: Article

References (29)

1. Riddell S.R. Engineering antitumor immunity by T-cell adoptive immunotherapy. Hematology Am Soc Hematol Educ Program 2007 (2007) 250-256
2. Eaton D., Gilham D.E., O'Neill A., and Hawkins R.E. Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions. Gene Ther 9 8 (2002) 527-535
3. Rosenberg S.A., Lotze M.T., Yang J.C., Aebersold P.M., Linehan W.M., Seipp C.A., et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 210 4 (1989) 474-484
4. Strand S., Hofmann W.J., Hug H., Müller M., Otto G., Strand D., et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?. Nat Med 2 12 (1996) 1361-1366
5. O'Connell J., O'Sullivan G.C., Collins J.K., and Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184 3 (1996) 1075-1082
6. Gastman B.R., Johnson D.E., Whiteside T.L., and Rabinowich H. Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events. Blood 95 6 (2000) 2015-2023
7. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., and Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274 32 (1999) 22532-22538
8. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17 6 (1998) 1675-1687
9. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 4 (1998) 481-490
10. Yin X.M. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369 (2006) 7-19
11. Majewski N., Nogueira V., Robey R.B., and Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 24 2 (2004) 730-740
12. Krueger A., Fas S.C., Baumann S., and Krammer P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 193 (2003) 58-69
13. Dotti G., Savoldo B., Pule M., Straathof K.C., Biagi E., Yvon E., et al. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood 105 12 (2005) 4677-4684
14. Charo J., Finkelstein S.E., Grewal N., Restifo N.P., Robbins P.F., and Rosenberg S.A. Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res 65 5 (2005) 2001-2008
15. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400 6747 (1999) 886-891
16. Liu C.M., Liu D.P., Dong W.J., and Liang C.C. Retrovirus vector-mediated stable gene silencing in human cell. Biochem Biophys Res Commun 313 3 (2004) 716-720
17. Lamers C.H., Willemsen R.A., Luider B.A., Debets R., and Bolhuis R.L. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer. Cancer Gene Ther 9 7 (2002) 613-623
18. Kershaw M.H., Teng M.W., Smyth M.J., and Darcy P.K. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol 5 12 (2005) 928-940
19. Stagg J., Johnstone R.W., and Smyth M.J. From cancer immunosurveillance to cancer immunotherapy. Immunol Rev 220 (2007) 82-101
20. Fulda S., Meyer E., Friesen C., Susin S.A., Kroemer G., and Debatin K.M. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 20 9 (2001) 1063-1075
21. Cuvillier O., Edsall L., and Spiegel S. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem 275 21 (2000) 15691-15700
22. Gardini A., Ercolani G., Riccobon A., Ravaioli M., Ridolfi L., Flamini E., et al. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. J Surg Oncol 87 1 (2004) 46-52
23. Lucas K.G., Salzman D., Garcia A., and Sun Q. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease. Cancer 100 9 (2004) 1892-1901
24. Belka C., Rudner J., Wesselborg S., Stepczynska A., Marini P., Lepple-Wienhues A., et al. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Oncogene 19 9 (2000) 1181-1190
25. + cytotoxic regulatory T cell lines from human umbilical cord blood. Exp Hematol 35 2 (2007) 287-296
26. 4. Nat Immunol 3 3 (2002) 237-243
27. + regulatory thymocytes. Blood 102 12 (2003) 4107-4114
28. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., and Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226 4678 (1984) 1097-1099
29. Naik P., Karrim J., and Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev 10 17 (1996) 2105-2116